Skip to main content
. 2011 Mar 7;4:47–53. doi: 10.2147/JPR.S15380

Table 3.

Summary of adverse events

DETP (n = 68) Placebo (n = 66)
Adverse events, n (%) 2 (3.0%) 3 (4.5%)
Skin
  Pruritus 1 (1.5%) 2a (3.0%)
  Other (application site burning) 0 (0.0%) 1 (1.5%)
Body as a whole
  Allergic reaction 1 (1.5%) 0 (0.0%)

Note:

a

One event led to discontinuation of the study treatment.

Abbreviations: DETP, diclofenac epolamine topical patch; n, number of patients.